Current or New Cytomegalovirus Antivirals and Novel Animal Model Strategies

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|9|4|286-299

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.9, Iss.4, 2010-09, pp. : 286-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus antivirals and development of improved animal models

By McGregor Alistair   Choi K. Yeon  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1245-1265

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation: Comparing Valaciclovir Prophylaxis with Current Practice

By Mauskopf J.A.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 239-251

Adis International

Access to resources Recommend Favorite

Data on the use of antivirals to treat cytomegalovirus infection in infants are limited, with ganciclovir being the current first choice

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 5, 2010-05 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Antivirals: current state of the art

By De Clercq Erik  

Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. : 393-405

Future Medicine

Access to resources Recommend Favorite

Antivirals/immunosuppressants: Multidrug-resistant cytomegalovirus: case report

By  

Reactions Weekly, Vol. 1, Iss. 1408, 2012-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite